Elanco Animal Health EBITDA 2016-2023 | ELAN
Elanco Animal Health annual and quarterly EBITDA history from 2016 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Elanco Animal Health EBITDA for the quarter ending December 31, 2023 was $0.145B, a 10.49% decline year-over-year.
- Elanco Animal Health EBITDA for the twelve months ending December 31, 2023 was $-0.149B, a 116.87% decline year-over-year.
- Elanco Animal Health 2023 annual EBITDA was $-0.149B, a 116.87% decline from 2022.
- Elanco Animal Health 2022 annual EBITDA was $0.883B, a 128.76% increase from 2021.
- Elanco Animal Health 2021 annual EBITDA was $0.386B, a 305.32% decline from 2020.
| Elanco Animal Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-149 |
| 2022 | $883 |
| 2021 | $386 |
| 2020 | $-188 |
| 2019 | $499 |
| 2018 | $481 |
| 2017 | $86 |
| 2016 | $229 |
| 2015 | $-21 |
| Elanco Animal Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $145 |
| 2023-09-30 | $-843 |
| 2023-06-30 | $195 |
| 2023-03-31 | $354 |
| 2022-12-31 | $162 |
| 2022-09-30 | $191 |
| 2022-06-30 | $218 |
| 2022-03-31 | $312 |
| 2021-12-31 | $101 |
| 2021-09-30 | $111 |
| 2021-06-30 | $-9 |
| 2021-03-31 | $183 |
| 2020-12-31 | $-56 |
| 2020-09-30 | $-143 |
| 2020-06-30 | $-20 |
| 2020-03-31 | $31 |
| 2019-12-31 | $104 |
| 2019-09-30 | $100 |
| 2019-06-30 | $152 |
| 2019-03-31 | $143 |
| 2018-12-31 | $118 |
| 2018-09-30 | $165 |
| 2018-06-30 | $44 |
| 2018-03-31 | $154 |
| 2017-12-31 | |
| 2017-09-30 | $-11 |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.552B | $4.417B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
| Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
| DaVita (DVA) | United States | $11.709B | 15.93 |
| Chemed (CHE) | United States | $8.472B | 26.30 |
| Encompass Health (EHC) | United States | $8.259B | 21.26 |
| Option Care Health (OPCH) | United States | $5.147B | 19.48 |
| RadNet (RDNT) | United States | $3.314B | 96.80 |
| Amedisys (AMED) | United States | $2.999B | 21.25 |
| LifeStance Health (LFST) | United States | $2.370B | 0.00 |
| Astrana Health (ASTH) | United States | $2.057B | 25.68 |
| Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
| U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
| Pennant (PNTG) | United States | $0.624B | 36.46 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.323B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |